Kunbin Ke

Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular Carcinoma

Zhong-Kun Xia, Wei Wang, Jian-Ge Qiu et al. · Frontiers in Pharmacology · 2021 · 37 citations · Full text

<p>Extracellular Matrix–Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer</p>

Liangliang Qing, Peng Gu, Mingsheng Liu et al. · OncoTargets and Therapy · 2020 · 33 citations · Full text

Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer

Xinan Shi, Hongjian Li, Anhua Shi et al. · Oncology Reports · 2018 · 28 citations · Full text

The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer

Chao Dong, Yin Chen, Hongjian Li et al. · International Journal of Biological Sciences · 2019 · 25 citations · Full text

Econazole nitrate inhibits PI3K activity and promotes apoptosis in lung cancer cells

Chao Dong, Runxiang Yang, Hongjian Li et al. · Scientific Reports · 2017 · 21 citations · Full text